András Matolcsy
Visiting Professor
E-mail: andras.matolcsy@ki.se
Visiting address: Nobels väg 7, 17165 Solna
Postal address: H5 Laboratoriemedicin, H5 Patologi, 141 52 Huddinge
About me
- Visiting Professor of Pathology at the Department of Laboratory Medicine from January 1, 2020,
Primary position: Professor and Head of the Department of Pathology and Experimental Cancer Research, Semmelweis University, Hungary,
Research
- Professor András Matolcsy has been a leading cancer researcher for almost four decades. He has focused primarily on lymphoma and leukemia and is particularly interested in the transformation from indolent cancer to an aggressive, fast-growing form with a much worse prognosis. Matolcsy has made some very important findings in this area, including the cells’ heterogeneity in cancer and the evolution of drug resistance.
András Matolcsy heads the Department of Pathology and Experimental Cancer Research at Semmelweis University with a staff of more than 100. One current major project at the department is systematically charting cancer genetics in Hungary compared to international data. Preliminary results show that some cancers show significant similarity in different parts of the world, while other cancer diagnoses show significant geographical differences, especially in terms of the number of mutations.
Text: From Cell to Society, 2020
Articles
- Article: JOURNAL OF PATHOLOGY CLINICAL RESEARCH. 2024;10(1):e351
- Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(3):295-313
- Article: BRITISH JOURNAL OF CANCER. 2023;129(3):455-465
- Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2023;25(8):555-568
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(6):5802
- Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2022;24(3):224-240
- Article: CYTOMETRY PART B-CLINICAL CYTOMETRY. 2022;101(2):159-166
- Article: PATHOLOGY. 2022;54(1):95-103
- Article: HEMATOLOGICAL ONCOLOGY. 2021;39(4):513-520
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(2):355-364
- Article: ORVOSI HETILAP. 2021;162(13):488-496
- Article: PATHOLOGY & ONCOLOGY RESEARCH. 2020;26(4):2765-2772
- Article: GENES. 2020;11(7):E785-785
- Article: MODERN PATHOLOGY. 2020;33(5):812-824
- Article: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2020;79(2):176-183
- Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(1):85-93
- Article: PATHOLOGY. 2019;51(3):301-307
- Article: PATHOLOGY & ONCOLOGY RESEARCH. 2019;25(2):647-652
- Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2018;20(6):777-788
- Article: ANNALS OF HEMATOLOGY. 2018;97(11):2145-2152
- Article: EXPERIMENTAL AND MOLECULAR PATHOLOGY. 2018;105(2):161-165
- Article: VIRCHOWS ARCHIV. 2018;473(4):453-462
- Article: LEUKEMIA RESEARCH. 2018;65:42-48
- Article: PATHOLOGY & ONCOLOGY RESEARCH. 2018;24(1):83-88
- Article: HEMATOLOGICAL ONCOLOGY. 2017;35(4):741-745
- Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2017;25(8):1020-1024
- Article: HEMATOLOGICAL ONCOLOGY. 2017;35(1):58-63
- Article: ORVOSI HETILAP. 2017;158(6):220-228
- Article: ONCOTARGET. 2016;7(46):74686-74700
- Article: HAEMATOLOGICA. 2014;99(6):1041-1049
- Show more
All other publications
- Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19:s279
- Editorial comment: HAEMATOLOGICA. 2019;104(1):e38-e41
- Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2018;101:S11